Login / Signup

Adjuvant stereotactic fractionated radiotherapy to the resection cavity in recurrent glioblastoma - the GlioCave study (NOA 17 - ARO 2016/3 - DKTK ROG trial).

Christoph StraubeHagen ScherbJens GemptJan KirschkeClaus ZimmerFriederike Schmidt-GrafBernhard MeyerStephanie E Combs
Published in: BMC cancer (2018)
The trial was prospectively registered at clinicaltrials.gov ( NCT02715297 , registration date February 29th, 2016). The protocol presented hereby refers to the version 1.2 of the protocol (January 11th, 2017).
Keyphrases
  • study protocol
  • early stage
  • randomized controlled trial
  • phase iii
  • phase ii
  • clinical trial
  • brain metastases
  • radiation therapy
  • small cell lung cancer
  • open label
  • squamous cell carcinoma
  • radiation induced